J.K. Wall

Elanco, a division of Eli Lilly and Co., will spend $300 million and an undisclosed “contingent consideration” to buy all rights to a popular dairy cow hormone and its sales and manufacturing operations from St. Louis-based Monsanto Co. Elanco has been selling the supplement, called Posilac, outside the United States for a decade. Now Elanco […]

Clarian Health Ventures found its latest investment in Minnesota via a Wisconsin venture capital firm. But the company was right under Clarian’s nose in Indianapolis. Clarian Health Ventures, the venture capital arm of the Indianapolis-based hospital system, joined a gaggle of investors to pump $30 million into Minnesota-based Celleration Inc. The company has developed and […]

Indianapolis-based Pharmakon LTC Pharmacy Inc. will pay an average of $50,000 a year to each of the 52 employees it plans to add in the next five years. The institutional pharmacy will move to a larger headquarters and warehouse in Carmel as part of its expansion, Indiana Economic Development Corp. said today. The $1.2 million […]

McGowan Insurance Group Inc. plans to spend $2.5 million to build its new headquarters at 340 N. Capitol Ave. As part of the expansion, McGowan will also add 13 jobs. The office building will occupy what is now vacant land east of Bourbon Street Distillery. McGowan announced the plan this morning. The 75-year-old insurance agency […]

Bad news for one of Lilly’s up-and-coming drugs. The Food and Drug Administration warned health professionals today that the diabetes drug Byetta might be linked to six cases of severe inflammation of the pancreas, or pancreatitis, according to MarketWatch. All six patients were hospitalized and two died. The FDA advised doctors to discontinue Byetta promptly […]

Conseco Inc. recorded a massive second quarter loss because of a $500 million accounting charge from a proposed spin-off of its long-term care business. Absent that special charge, the Carmel-based insurer would have swung to a profit compared with a loss in the same quarter a year earlier. For the three months ended June 30, […]

Stock in Conseco Inc. moved up more than 8 percent today after the Carmel-based insurer announced that it would take a $1.2 billion hit to split off its troubled long-term care business as an independent entity owned by policyholders. The shares traded near $8.32 per share. Conseco Senior Health Insurance Co. will be transferred to […]

Conseco Inc. will take a $1.2 billion hit to split off its troubled long-term care business as an independent entity owned by policyholders. The Carmel-based insurance company announced plans this morning to transfer Conseco Senior Health Insurance Co. to an independent trust based in Pennsylvania. The deal, which requires approval by Pennsylvania insurance regulators, is […]

Arcadia Resources Inc. narrowed its losses during its fiscal first quarter. The Indianapolis-based home health care company lost $3.3 million in the period ended June 30 compared with a $3.7 million loss in the same quarter last year. The loss of 2 cents per share was worse than the breakeven anticipated by the sole analyst […]

The future of medicine is personal. That’s been the mantra of the pharmaceutical industry for the last decade-since the human genome was sequenced for the first time. But before Eli Lilly and Co. and its peers can develop and sell drugs that treat only patients with a specific gene, it needs sophisticated devices to test if a patient has that gene. And those devices need sophisticated software to make them run. That’s where The RND Group Inc. comes in. The…

But the Indianapolis-based drugmaker hopes Indiana sees no net loss of jobs from its restructuring moves. The Aug. 6 announcement is part of a quickening effort by Lilly to reduce overhead costs before it loses patent protection on a string of drugs, which now make up 60 percent of its revenue. In Greenfield, Lilly is selling its labs for toxicology and other drug development tests to New Jersey-based Covance Inc., a contract research organization. Covance is paying Lilly $50 million…

Eli Lilly and Co. will shed about 440 jobs after the sale of its Greenfield Laboratories and outsourcing other work. But the Indianapolis-based drugmaker hopes Indiana sees no net loss of jobs from its restructuring moves. The announcements this morning are part of a quickening effort by Lilly to reduce overhead costs before it loses […]

Second-quarter sales and profits rose by double digits for Eli Lilly and Co., but overhead increased just as fast as the company worked feverishly to find new revenue sources before key patents expire. Investors yawned today after the Indianapolis-based drugmaker met Wall Street expectations of 99 cents per share. Lilly shares inched up 68 cents, […]

Wall Street rejoiced today after WellPoint Inc. posted second-quarter profit that exceeded analysts’ estimates. Investors bid up shares of the Indianapolis-based health insurer as much as 9 percent. As of late this morning, the stock traded at $52.06, up 6.8 percent. WellPoint stock rose along with broader markets, which surged as the price of crude […]